Found 6 matching trials
Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer
EARLY_PHASE1This is a phase 1, single-center, open-label study that enrolls adult subje...
Location
Lineberger Comprehensive Cancer Center
Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma
PHASE1The body has different ways of fighting infections and disease. No single w...
Location
Emory - Winship Cancer Institute
3rd Generation GD-2 Chimeric Antigen Receptor and iCaspase Suicide Safety Switch, Neuroblastoma, GRAIN
PHASE1Subjects that have relapsed or refractory neuroblastoma are invited to take...
Status
Active Not Recruiting
Location
Houston Methodist Hospital
3RD GENERATION GD2 SPECIFIC CHIMERIC ANTIGEN RECEPTOR TRANSDUCED AUTOLOGOUS NATURAL KILLER T-CELLS FOR NEUROBLASTOMA
PHASE1This research study is for patients that have a cancer called Neuroblastoma...
Location
Texas Children's Hospital
GD2-CAR T Cells for Pediatric Brain Tumours
PHASE1The purpose of this study is to test the safety and efficacy of iC9-GD2-CAR...
Location
Ospedale Pediatrico Bambino Gesรน
iC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma and Neuroblastoma
PHASE1The purpose of this study is to find the largest safe dose of GD2-T cells (...
Status
Active Not Recruiting
Location
Houston Methodist Hospital